Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1996
03/26/1996US5502050 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
03/26/1996US5501969 Bone disorders, antitumor
03/26/1996US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant
03/22/1996CA2158591A1 Fatty acid treatment
03/21/1996WO1996008557A1 Human inositol monophosphatase h1
03/21/1996WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
03/21/1996WO1996008503A1 Intermediates for dinucleotide and oligonucleotide analogues
03/21/1996WO1996008489A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
03/21/1996WO1996008485A1 Quinoxalinedione nmda receptor antagonists
03/21/1996WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996WO1996008271A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996WO1996008268A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996WO1996008240A1 Use of aromatic halides for treating mammalian cell proliferation
03/21/1996DE19534744A1 Neues pharmazeutisches Produkt New pharmaceutical product
03/21/1996CA2199939A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996CA2199730A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996CA2198900A1 Intermediates for dinucleotide and oligonucleotide analogues
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/20/1996EP0702013A2 Imidazopyridines
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0702010A1 Benzopyranderivatives, process for their preparation and pharmaceutical compositions containing them
03/20/1996EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent
03/20/1996EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701817A2 Medicaments for treating vascular leak syndrome
03/20/1996EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells
03/20/1996EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
03/20/1996EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host
03/20/1996EP0701560A1 Bicyclic ether derivatives and their use as 5-lipoxygenase inhibitors
03/20/1996EP0701555A1 Indazole derivatives
03/20/1996EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/20/1996EP0701546A1 Aromatic acetylcholinesterase inhibitors
03/20/1996EP0701443A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders
03/20/1996EP0701441A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
03/20/1996EP0701439A1 Stable copper(i) complexes and methods related thereto
03/20/1996EP0659083A4 Prevention and treatment of peripheral neuropathy.
03/20/1996EP0586490B1 Derivatives of perhydroisoindol, their preparation, and pharmaceutical compositions containing them
03/20/1996EP0556332B1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders
03/20/1996CN1119014A Benzopyranes as potassium channel openers
03/20/1996CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines
03/20/1996CN1118782A Cyclohexan-derivative, preparation and application for treatment of same
03/20/1996CN1031339C Process for preparation of heterocyclically substituted phenylacetic acid derivatives
03/20/1996CA2158517A1 Aminomethylphosphonic and aminomethylphosponic acid derivates and their use for treating degenerative joint disorders
03/19/1996US5500434 Mixture of trandolapril and felodipine
03/19/1996US5500429 Cardiovascular
03/19/1996US5500417 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents
03/19/1996US5500412 Selective stimulation and inhibition of receptor signals, wound healing, antitumor agents
03/19/1996US5500225 Monitoring melatonin levels and administering to compensate for deficiencies
03/19/1996CA2109800C N-hydroxyurea derivatives which inhibit lipoxygenase
03/19/1996CA2014208C Selective blocking of spontaneously-active dopamine neurones in ventral tegmental area
03/16/1996CA2158225A1 Imidazopyridines
03/14/1996WO1996007737A1 A novel haemopoietin receptor
03/14/1996WO1996007653A1 Endothelin receptor antagonists
03/14/1996WO1996007649A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996WO1996007641A1 Heterocyclic derivative and medicine
03/14/1996WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996WO1996007422A1 Use of il-4 for potentiation of chemotherapeutic agents
03/14/1996WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996WO1996007405A1 Excitatory amino acid receptor antagonists
03/14/1996WO1996007404A1 Use of selegiline to prolong life span
03/14/1996WO1996007402A1 Triphenylethylenes for the prevention and treatment of osteoporosis
03/14/1996WO1996007400A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
03/14/1996CA2199518A1 Heterocyclic derivative and medicine
03/14/1996CA2199508A1 Excitatory amino acid receptor antagonists
03/14/1996CA2199262A1 Use of il-4 for potentiation of chemotherapeutic agents
03/14/1996CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996CA2198477A1 Morpholine derivatives and their use as therapeutic agents
03/14/1996CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996CA2197873A1 A novel haemopoietin receptor
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/13/1996EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation
03/13/1996EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them
03/13/1996EP0700896A1 Photochemically cleavable metal chelating agents and compositions containing them
03/13/1996EP0700679A1 Injectable liposomal compositions
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700396A1 Piperidine derivatives, their preparation and use
03/13/1996EP0700388A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
03/13/1996EP0700387A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
03/13/1996EP0700386A1 Neurokinin receptor antagonists
03/13/1996EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
03/13/1996EP0700382A1 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their prepation and pharmaceutical compositions containing same
03/13/1996EP0700380A1 N-alkylthio polyamine derivatives as radioprotective agents
03/13/1996EP0700378A1 Compounds which release nitric oxide
03/13/1996EP0700376A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
03/13/1996EP0700296A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
03/13/1996EP0700288A1 Inhibition of hair growth
03/13/1996EP0700286A1 Apoptosis inhibitors for treating neurodegenerative diseases
03/13/1996EP0700282A1 Inhibition of hair growth
03/13/1996EP0618899B1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
03/13/1996EP0566661B1 Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals
1 ... 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 ... 1564